HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G To Hike Prices At Least 3%, Expects Others To Follow

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble expects that an across-the-board price increase of at least 3% – spurred by higher commodity costs – will prompt its competitors to raise product prices as well.

You may also be interested in...



P&G Defends Savings/Growth Strategy, Plans To Slash More Prices In FY 2013

P&G will roll back about $400 million of the $3.5 billion in pricing increases taken in fiscal year 2012, in an effort to include beauty and health-care products. Beauty sales declined 4% on the year, the firm reported.

P&G's Q2 Earnings Burdened By Rising Costs, But Respite In Sight

Procter & Gamble expects commodity costs to drop over the next two quarters, but for the firm’s FY 2012 second quarter, they contributed to a 49% decline in earnings to $1.69 billion.

P&G Beauty Growth Abroad Offsets Challenges In U.S. In Q4

Growth of Procter & Gamble's beauty business in developing markets kept the unit afloat in the fourth quarter and fiscal year 2011, despite challenges in the U.S. including the recall of Olay UV products and a continuing rebuild of Pantene equity.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017826

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel